QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Title of each class |
Trading Symbols |
Name of each exchange on which registered | ||
one-half of one redeemable warrant |
||||
| Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
| ☒ | Smaller reporting company | |||||
| Emerging growth company | ||||||
Page |
||||
Part I. Financial Information |
||||
| 1 | ||||
| 1 | ||||
| 2 | ||||
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 16 | ||||
| 19 | ||||
| 19 | ||||
Part II. Other Information |
||||
| 19 | ||||
| 19 | ||||
| 20 | ||||
| 20 | ||||
| 20 | ||||
| 20 | ||||
| 20 | ||||
| 21 | ||||
March 31, 2022 (Unaudited) |
December 31, 2021 |
|||||||
| ASSETS |
||||||||
| Current assets |
||||||||
| Cash |
$ | $ | ||||||
| Prepaid expenses |
||||||||
| |
|
|
|
|||||
| Total Current Assets |
||||||||
| Investments held in Trust Account |
||||||||
| |
|
|
|
|||||
| TOTAL ASSETS |
$ |
$ |
||||||
| |
|
|
|
|||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT |
||||||||
| Current liabilities |
||||||||
| Accrued expenses |
$ | $ | ||||||
| |
|
|
|
|||||
| Total Current Liabilities |
||||||||
| Warrant liabilities |
||||||||
| Deferred underwriting fee payable |
||||||||
| |
|
|
|
|||||
| Total Liabilities |
||||||||
| |
|
|
|
|||||
| Commitments and Contingencies (Note 6) |
||||||||
| Class A common stock subject to possible redemption, $ |
||||||||
| |
|
|
|
|||||
| Stockholders’ Deficit |
||||||||
| Preferred stock, $ |
— | — | ||||||
| Class A common stock, $ |
||||||||
| Class B common stock, $ |
||||||||
| Additional paid-in capital |
||||||||
| Accumulated deficit |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Total Stockholders’ Deficit |
( |
) |
( |
) | ||||
| |
|
|
|
|||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT |
$ |
$ |
||||||
| |
|
|
|
|||||
For the Three Months Ended March 31, |
||||||||
2022 |
2021 |
|||||||
Formation and operational costs |
$ | $ | ||||||
Loss from operations |
( |
) |
( |
) | ||||
Other income: |
||||||||
Change in fair value of warrant liabilities |
||||||||
Transaction costs incurred in connection with warrant liabilities |
— | ( |
) | |||||
Interest earned on investments held in Trust Account |
||||||||
Total other income, net |
||||||||
Net income |
$ |
$ |
||||||
Weighted average shares outstanding, Class A common stock |
||||||||
Basic and diluted net income per share, Class A common stock |
$ |
$ |
||||||
Basic weighted average shares outstanding, Class B common stock |
||||||||
Basic net income per share, Class B common stock |
$ |
$ |
||||||
Diluted weighted average shares outstanding, Class B common stock |
||||||||
Diluted net income per share, Class B common stock |
$ |
$ |
||||||
Class A Common Stock |
Class B Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Total Stockholders’ Deficit |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
| Balance — January 1, 2022 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
| Net incom e |
— | — | — | — | — | |||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance – March 31, 2022 (unaudited) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Class A Common Stock |
Class B Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Total Stockholders’ Deficit |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
| Balance — January 1, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||||
| Cash paid in excess of fair value for Private Placement Warrant s |
— | — | — | — | — | |||||||||||||||||||||||
| Accretion for Class A common stock subject to redemption amount |
— | — | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
| Net income |
— | — | — | — | — | |||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance – March 31, 2021 (unaudited) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
For the Three Months Ended March 31, |
||||||||
2022 |
2021 |
|||||||
| Cash Flows from Operating Activities: |
||||||||
| Net income |
$ | $ | ||||||
| Adjustments to reconcile net income to net cash used in operating activities: |
||||||||
| Interest earned on marketable securities held in Trust Account |
( |
) | ( |
) | ||||
| Change in fair value of warrant liabilities |
( |
) | ( |
) | ||||
| Transaction costs incurred in connection with warrant liabilities |
— | |||||||
| Changes in operating assets and liabilities: |
||||||||
| Prepaid expenses |
( |
) | ||||||
| Accrued expenses |
( |
) | ||||||
| |
|
|
|
|||||
| Net cash used in operating activities |
( |
) |
( |
) | ||||
| |
|
|
|
|||||
| Cash Flows from Investing Activities: |
||||||||
| Investment of cash in Trust Account |
( |
) | ||||||
| |
|
|
|
|||||
| Net cash used in investing activities |
( |
) | ||||||
| |
|
|
|
|||||
| Cash Flows from Financing Activities: |
||||||||
| Proceeds from sale of Units, net of underwriting discounts paid |
— | |||||||
| Proceeds from sale of Private Placement Warrants |
— | |||||||
| Proceeds from promissory notes – related party |
— | |||||||
| Repayment of promissory notes – related party |
— | ( |
) | |||||
| Payment of offering costs |
— | ( |
) | |||||
| |
|
|
|
|||||
| Net cash provided by financing activities |
— | |||||||
| |
|
|
|
|||||
| Net Change in Cash |
( |
) |
||||||
| Cash – Beginning |
||||||||
| |
|
|
|
|||||
| Cash – Ending |
$ |
$ |
||||||
| |
|
|
|
|||||
| Non-cash investing and financing activities: |
||||||||
| Accretion for Class A common stock to redemption amount |
$ | — | $ | |||||
| |
|
|
|
|||||
| Deferred underwriting fee payable |
$ | — | $ | |||||
| |
|
|
|
|||||
| Initial value of warrant liability |
$ | — | $ | |||||
| |
|
|
|
|||||
| Gross proceeds |
$ | |||
| Less: |
||||
| Proceeds allocated to Public Warrants |
$ | ( |
) | |
| Class A common stock issuance costs |
( |
) | ||
| Plus: |
||||
| Accretion of carrying value to redemption value |
$ | |||
| |
|
|||
| Class A common stock subject to possible redemption |
$ | |||
| |
|
For the Three Months Ended March 31, 2022 |
For the Three Months Ended March 31, 2021 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Basic net income per common share |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income, as adjusted |
$ | $ | $ | $ | ||||||||||||
Denominator: |
||||||||||||||||
Basic weighted average shares outstanding |
||||||||||||||||
Basic net income per common share |
$ | $ | $ | $ | ||||||||||||
Diluted net income per common share |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income, as adjusted |
$ | $ | $ | $ | ||||||||||||
Denominator: |
||||||||||||||||
Diluted weighted average shares outstanding |
||||||||||||||||
Diluted net income per common share |
$ | $ | $ | $ | ||||||||||||
| • | in whole and not in part; |
| • | at a price of $ |
| • | upon a minimum of |
| • | if, and only if, the closing price of the Class A common stock equals or exceeds $ |
Level 1: |
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. | |
Level 2: |
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. | |
Level 3: |
Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. | |
Description |
Level |
March 31, 2022 |
December 31, 2021 |
|||||||||
Assets: |
||||||||||||
Investments held in Trust Account – U.S. Treasury Securities Money Market Fund |
1 | $ | $ | |||||||||
Liabilities: |
||||||||||||
Warrant Liability – Public Warrants |
1 | $ | $ | |||||||||
Warrant Liability – Private Placement Warrants |
2 | $ | $ | |||||||||
Private Placement Warrants |
Public Warrants |
Warrant Liabilities |
||||||||||
Fair value as of January 1, 2021 |
$ | $ | $ | |||||||||
Initial measurement on January 14, 2021 |
||||||||||||
Change in fair value |
( |
) | ( |
) | ( |
) | ||||||
Transfer to level 1 |
( |
) | ( |
) | ||||||||
Fair value as of March 31, 2021 |
$ | $ | ||||||||||
| 101.INS* | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | |
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document | |
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | |
| 101.LAB* | Inline XBRL Taxonomy Extension Labels Linkbase Document | |
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
| 104* | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101.INS) | |
| (1) | Previously filed as an exhibit to our Current Report on Form 8-K filed on January 15, 2021 and incorporated by reference herein. |
| (2) | Previously filed as an exhibit to our Form S-1 filed on December 22, 2020 and incorporated by reference herein. |
| * | Filed herewith. |
| ** | Furnished. |
ATHLON ACQUISITION CORP. | ||||||
| Date: May 3, 2022 | By: | /s/ Chris Hickey | ||||
| Name: | Chris Hickey | |||||
| Title: | Chief Executive Officer and Director | |||||
| (Principal Executive Officer) | ||||||
| By: | /s/ David Poltack | |||||
| Name: | David Poltack | |||||
| Title: | Chief Financial Officer (Principal Accounting and Financial Officer) | |||||